EUR 0.08
(-1.89%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 6.06 Million EUR | 60.95% |
2022 | 3.77 Million EUR | 1690.72% |
2021 | -237 Thousand EUR | 63.03% |
2020 | -641 Thousand EUR | -113.58% |
2019 | 4.71 Million EUR | -20.81% |
2018 | 5.95 Million EUR | 29.6% |
2017 | 4.59 Million EUR | 22.65% |
2016 | 3.74 Million EUR | 0.44% |
2015 | 3.73 Million EUR | 8.84% |
2014 | 3.42 Million EUR | 30.07% |
2013 | 2.63 Million EUR | 200.28% |
2012 | 878.09 Thousand EUR | -27.15% |
2011 | 1.2 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | -464 Thousand EUR | 0.0% |
2023 Q4 | 4.93 Million EUR | 0.0% |
2023 Q2 | -448 Thousand EUR | 0.0% |
2023 FY | 6.06 Million EUR | 60.95% |
2022 Q2 | -128 Thousand EUR | 0.0% |
2022 FY | 3.77 Million EUR | 1690.72% |
2022 Q4 | 59 Thousand EUR | 0.0% |
2021 FY | -237 Thousand EUR | 63.03% |
2021 Q2 | -30 Thousand EUR | 0.0% |
2021 Q4 | -207 Thousand EUR | 0.0% |
2020 Q4 | -265 Thousand EUR | 0.0% |
2020 FY | -641 Thousand EUR | -113.58% |
2020 Q2 | -376 Thousand EUR | 0.0% |
2019 Q2 | 2.18 Million EUR | 0.0% |
2019 Q4 | -458 Thousand EUR | 0.0% |
2019 FY | 4.71 Million EUR | -20.81% |
2018 Q2 | 2.99 Million EUR | 0.0% |
2018 FY | 5.95 Million EUR | 29.6% |
2018 Q4 | 2.96 Million EUR | 0.0% |
2017 Q2 | 2.11 Million EUR | 0.0% |
2017 FY | 4.59 Million EUR | 22.65% |
2017 Q4 | 2.48 Million EUR | 0.0% |
2016 Q2 | 1.62 Million EUR | 0.0% |
2016 FY | 3.74 Million EUR | 0.44% |
2016 Q4 | 2.12 Million EUR | 0.0% |
2015 FY | 3.73 Million EUR | 8.84% |
2015 Q4 | 1.81 Million EUR | 0.0% |
2015 Q2 | 1.91 Million EUR | 0.0% |
2014 Q4 | 1.94 Million EUR | 0.0% |
2014 Q2 | 1.48 Million EUR | 0.0% |
2014 FY | 3.42 Million EUR | 30.07% |
2013 FY | 2.63 Million EUR | 200.28% |
2013 Q4 | 1.43 Million EUR | 0.0% |
2013 Q2 | 1.2 Million EUR | 0.0% |
2012 Q1 | 86.67 Thousand EUR | 0.0% |
2012 Q2 | 86.67 Thousand EUR | 0.0% |
2012 Q3 | 86.67 Thousand EUR | 0.0% |
2012 Q4 | 32.89 Thousand EUR | -62.05% |
2012 FY | 878.09 Thousand EUR | -27.15% |
2011 Q3 | 80.4 Thousand EUR | 0.0% |
2011 Q4 | 86.67 Thousand EUR | 7.79% |
2011 FY | 1.2 Million EUR | 0.0% |
2011 Q1 | 80.4 Thousand EUR | 0.0% |
2011 Q2 | 80.4 Thousand EUR | 0.0% |
2010 Q4 | 80.4 Thousand EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Crossject Société Anonyme | 5.66 Million EUR | -7.114% |
Safe Orthopaedics SA | 10.7 Million EUR | 43.316% |
Amplitude Surgical SA | 23.96 Million EUR | 74.678% |
Sartorius Stedim Biotech S.A. | 749 Million EUR | 99.19% |
EssilorLuxottica Société anonyme | 12.65 Billion EUR | 99.952% |
bonyf N.V. | 66.3 Thousand EUR | -9051.234% |